---
layout: minimal-medicine
title: Fludarabine
---

# Fludarabine
### Generic Name
Fludarabine

### Usage

Fludarabine is primarily used to treat chronic lymphocytic leukemia (CLL) in adults.  It's specifically indicated for patients whose CLL hasn't responded to, or has worsened during, treatment with at least one standard regimen including an alkylating agent.  

Importantly, fludarabine also sees off-label use in several other conditions, including:

* **Relapsed or refractory mantle cell lymphoma:**  Fludarabine is often used in combination with other chemotherapy drugs to treat this type of lymphoma that has returned or hasn't responded to previous treatment.
* **Acute myeloid leukemia (AML):**  Both in newly diagnosed cases and in those that are refractory (resistant to treatment) or high/poor risk, fludarabine may be part of a combination therapy regimen.
* **Hematopoietic stem cell transplant (HSCT):** Fludarabine is sometimes used as part of the conditioning regimen before an allogeneic (donor) HSCT, helping prepare the body for the transplant.
* **Other lymphomas and leukemias:** Fludarabine finds use in various other blood cancers, often as part of complex combination therapies, though these uses are considered off-label.  These include certain types of non-Hodgkin lymphoma and Waldenström macroglobulinemia.

It is crucial to remember that off-label uses are not formally approved by regulatory bodies and should only be considered under the guidance of an experienced oncologist.


### Dosage

Fludarabine dosage is highly individualized and depends on several factors, including the specific condition being treated, the patient's body surface area (BSA),  renal function, and the presence of other medications.  Dosage forms include intravenous (IV) injection and oral tablets.

**Adult Dosage (On-label and common Off-label regimens):**

The most common on-label dosage for CLL is 25 mg/m² intravenously administered daily for 5 consecutive days, repeated every 28 days.  The number of cycles depends on the response.  Oral fludarabine is also used, but the dosage and administration schedule differ (see prescribing information for exact details).  Off-label regimens often involve combining fludarabine with other chemotherapy drugs (e.g., cyclophosphamide, rituximab, cytarabine) and have varied dosing schedules.  These regimens (FC, FCR, FR, OFAR, etc.) are complex and are strictly determined and monitored by the treating physician.


**Pediatric Dosage:**

Fludarabine use in children is primarily for relapsed acute lymphocytic leukemia (ALL) or AML, and as part of HSCT conditioning regimens.  Dosing is significantly different from adult regimens and is strictly determined by the treating physician based on the child's weight and overall health.  Intravenous administration is usual.


**Dosage Adjustments:**

Renal function significantly impacts fludarabine dosage.  Patients with reduced kidney function require lower doses to avoid toxic buildup.  Hepatic impairment may also necessitate dosage adjustments, though specific guidelines may vary.  Obesity may influence dosing strategies in certain contexts.  All dosage adjustments should be guided by the prescribing physician, considering individual patient factors and close monitoring.

### Side Effects

Fludarabine can cause a range of side effects, varying in frequency and severity.  

**Common Side Effects:**

* Fatigue
* Nausea and vomiting
* Anemia (low red blood cell count)
* Neutropenia (low white blood cell count)
* Thrombocytopenia (low platelet count)
* Hair loss (alopecia)


**Serious, but Less Common Side Effects:**

* Severe bone marrow suppression (leading to increased risk of infection and bleeding)
* Neurotoxicity (including peripheral neuropathy, seizures, and even coma)
* Autoimmune reactions (hemolytic anemia, thrombocytopenia)
* Pulmonary toxicity
* Tumor lysis syndrome (a rapid breakdown of cancer cells, leading to electrolyte imbalances)
* Renal failure
* Liver damage


Any unusual or concerning side effects must be reported to a healthcare provider immediately.


### How it Works

Fludarabine is an antimetabolite, meaning it interferes with the metabolic processes of rapidly dividing cells, particularly cancer cells.  It works by incorporating itself into DNA, disrupting its replication and repair. This ultimately leads to cell death.  Fludarabine preferentially targets cancer cells because they divide much faster than normal cells. However, this mechanism also explains its side effects on normal rapidly-dividing cells such as those in the bone marrow.


### Precautions

* **Hypersensitivity:** Fludarabine is contraindicated in patients with known hypersensitivity to it or its components.
* **Bone Marrow Suppression:**  Fludarabine severely suppresses bone marrow function; regular blood tests are crucial to monitor blood counts.
* **Renal Impairment:** Patients with impaired kidney function need dose adjustments or may be ineligible for treatment.
* **Hepatic Impairment:** Dose adjustments may be needed in patients with liver problems.
* **Pregnancy and Breastfeeding:**  Fludarabine is categorized as pregnancy category D, meaning it poses a risk to the fetus.  Women of childbearing age should use effective contraception.  Breastfeeding should be discontinued during treatment.
* **Interactions:**  Fludarabine can interact with many other medications, especially other chemotherapy drugs and immunosuppressants.  This necessitates careful monitoring and potential dose adjustments.
* **Vaccination:** Live vaccines should be avoided during and for a period after treatment.
* **Neurotoxicity:**  A close watch for signs of neurotoxicity (nervous system damage) is essential, as this can be serious.

### FAQs

* **How long does it take to see results?**  The response to fludarabine varies.  Some patients might experience improvements within weeks, while others may take longer.  Regular monitoring is crucial to assess treatment effectiveness.
* **How is fludarabine stored?**  Follow the storage instructions provided by your pharmacist. Generally, it should be stored at a cool temperature, away from light and moisture.
* **Can I drive while taking fludarabine?**  Fatigue is a common side effect; if you experience this, avoid driving or operating machinery.
* **What should I do if I miss a dose?** Consult your doctor or pharmacist immediately.  Do not attempt to double up on doses.
* **Is fludarabine safe for long-term use?**  Long-term use is not generally indicated, and the potential for long-term side effects necessitates close monitoring.

**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice.  Always consult with a healthcare professional for diagnosis, treatment, and management of any medical condition.  The information provided here should not be considered a substitute for professional medical advice.  Always refer to the official prescribing information for the most up-to-date and accurate details on fludarabine.
